Revista espanola de cardiologia最新文献

{"title":"Anglicismos por desidia","authors":"Fernando A. Navarro","doi":"10.1016/j.recesp.2026.02.007","DOIUrl":"10.1016/j.recesp.2026.02.007","url":null,"abstract":"","PeriodicalId":21299,"journal":{"name":"Revista espanola de cardiologia","volume":"79 10","pages":"Page 809"},"PeriodicalIF":4.2,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149071985","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Nuevas oportunidades y retos en el tratamiento anticoagulante","authors":"Francisco Marín, Inmaculada Roldán, en representación del Grupo de Trabajo de Trombosis Cardiovascular de la Sociedad Española de Cardiología","doi":"10.1016/j.recesp.2026.03.005","DOIUrl":"10.1016/j.recesp.2026.03.005","url":null,"abstract":"","PeriodicalId":21299,"journal":{"name":"Revista espanola de cardiologia","volume":"79 10","pages":"Pages 810-812"},"PeriodicalIF":4.2,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149071986","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Validación de un modelo de puntuación Z del VO2máx para la evaluación de la aptitud física en una población pediátrica española sana","authors":"Esteban Peiró-Molina,&nbsp;Arthur Gavotto,&nbsp;Julien Robert,&nbsp;Mathieu Andrianoely,&nbsp;Erika Rezola,&nbsp;Begoña Manso,&nbsp;Francisco-José Ferrer-Sargues,&nbsp;José Ignacio Carrasco-Moreno,&nbsp;Stefan Matecki,&nbsp;Alfred Hager,&nbsp;Naomi Gauthier,&nbsp;Suellen Moli Yin,&nbsp;Sophie Guillaumont,&nbsp;Thibault Mura,&nbsp;José Miguel Blanco Borreguero,&nbsp;Pascal Amedro,&nbsp;on behalf of the QUALIREHAB study group","doi":"10.1016/j.recesp.2026.02.003","DOIUrl":"10.1016/j.recesp.2026.02.003","url":null,"abstract":"<div><h3>Introduction and objectives</h3><div>Maximal oxygen uptake is the gold standard for assessing aerobic capacity in children and adolescents. Its interpretation requires robust reference models. A pediatric Z-score model has recently been developed, but external validation in independent cohorts is essential to confirm its applicability.</div></div><div><h3>Methods</h3><div>We conducted a multicenter validation study including a total of 1046 healthy participants (mean age, 12.0 <!--> <!-->± 2.6 years), composed of 2 cohorts: a prospective Spanish validation cohort (n <!--> <!-->=<!--> <!--> 175) and a previously published reference cohort (n <!--> <!-->=<!--> <!--> 871). The Z-score model was compared with historical weight- and height-based linear equations in terms of correlation, prediction error, and classification of impaired aerobic fitness. Subgroup analyses were performed by sex and body mass index.</div></div><div><h3>Results</h3><div>The Z-score model showed the strongest correlation between predicted and observed maximal oxygen uptake (R² <!--> <!-->=<!--> <!--> 0.70), outperforming weight-based (R² <!--> <!-->=<!--> <!--> 0.64) and height-based (R² <!--> <!-->=<!--> <!--> 0.66) equations. It yielded smaller prediction errors among body mass index groups and identified 14% of participants as having impaired aerobic fitness, compared with 20% and 23% using weight- and height-based reference models, respectively. The Z-score model showed improved consistency and reduced bias, particularly in overweight participants.</div></div><div><h3>Conclusions</h3><div>The pediatric Z-score model demonstrated superior accuracy, consistency, and classification reliability compared with linear equations in a large, independent Spanish cohort. Its adoption may enhance the interpretation of pediatric cardiopulmonary exercise testing, support early identification of reduced aerobic fitness, and guide prevention strategies and tailored interventions.</div><div>Registered on ClinicalTrials.gov (NCT04876209).</div></div>","PeriodicalId":21299,"journal":{"name":"Revista espanola de cardiologia","volume":"79 8","pages":"Pages 680-690"},"PeriodicalIF":4.2,"publicationDate":"2026-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148647181","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Punción transeptal para FOP con cierre de aneurisma del tabique auricular","authors":"Kun Wang,&nbsp;Yong-Kang Liu","doi":"10.1016/j.recesp.2025.11.009","DOIUrl":"10.1016/j.recesp.2025.11.009","url":null,"abstract":"","PeriodicalId":21299,"journal":{"name":"Revista espanola de cardiologia","volume":"79 8","pages":"Pages 732-733"},"PeriodicalIF":4.2,"publicationDate":"2026-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148660491","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Cribado antes de las pruebas de isquemia en el síndrome coronario crónico: ¿hasta dónde debemos llegar?","authors":"Joel Hernández Sevillano,&nbsp;Ana Devesa","doi":"10.1016/j.recesp.2026.02.006","DOIUrl":"10.1016/j.recesp.2026.02.006","url":null,"abstract":"","PeriodicalId":21299,"journal":{"name":"Revista espanola de cardiologia","volume":"79 8","pages":"Pages 667-669"},"PeriodicalIF":4.2,"publicationDate":"2026-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148634231","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Incidencia a 10 años e impacto pronóstico de la insuficiencia cardiaca incidente tras síndrome coronario agudo: estudio poblacional BEAT-HF","authors":"Josep Comín Colet,&nbsp;María Basalo,&nbsp;Marc Llagostera,&nbsp;Emili Vela,&nbsp;Júlia Folguera,&nbsp;Isaac Llaó,&nbsp;Josep Gómez-Lara,&nbsp;David Monterde,&nbsp;Jordi Piera-Jiménez,&nbsp;Gerard Carot-Sans,&nbsp;Raúl Ramos-Polo,&nbsp;José María Verdú-Rotellar,&nbsp;Núria José-Bazán,&nbsp;Laia Lorenzo-Esteller,&nbsp;Silvia Jovells,&nbsp;Andreea Cosa,&nbsp;Pedro Moliner,&nbsp;Mireia Andrés Villarreal,&nbsp;Cristina Enjuanes-Grau,&nbsp;Oona Meroño","doi":"10.1016/j.recesp.2026.02.004","DOIUrl":"10.1016/j.recesp.2026.02.004","url":null,"abstract":"<div><h3>Introduction and objectives</h3><div>Incident heart failure (iHF) impacts the downstream cardiovascular disease continuum, particularly after acute coronary syndromes (ACS). The aim of this study was to assess iHF after ACS from a population-based perspective, identify its risk factors, and analyze the associated clinical and resource burden.</div></div><div><h3>Methods</h3><div>Retrospective, population-based study including all individuals covered by the Catalonian public health care system, who were discharged after an ACS between January 1, 2011 and December 31, 2021. Integrated health care databases from multiple sources were used.</div></div><div><h3>Results</h3><div>Among 83 357 patients without previous HF who were discharged after ACS, 23.3% developed iHF during follow-up. The main risk factors for developing iHF after ACS included age (sHR, per year 1.03; 95%CI, 1.03-1.04), very low income (sHR, 2.08; 95%CI, 1.56-2.78), and Killip class II-III at presentation (sHR, 2.16; 95%CI, 2.06-2.27). Compared with patients without iHF, those who developed iHF had markedly higher rates of all-cause mortality (3.44-fold), major adverse cardiac events (2.75-fold), and substantially greater health care expenditure, mainly driven by hospitalizations.</div></div><div><h3>Conclusions</h3><div>One in 4 ACS survivors developed HF within 10 years, with major consequences for survival, morbidity, and health care costs. Socioeconomic status emerged as a determinant comparable to traditional clinical risk factors, suggesting the importance of targeted strategies to improve early identification and prevention of HF after ACS, particularly in socioeconomically vulnerable populations.</div><div>Registered at ClinicalTrials.gov (NCT06255418).</div></div>","PeriodicalId":21299,"journal":{"name":"Revista espanola de cardiologia","volume":"79 8","pages":"Pages 701-712"},"PeriodicalIF":4.2,"publicationDate":"2026-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148660487","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Selección de estándares para medir los resultados comunicados por el paciente en los servicios de cardiología del Sistema Nacional de Salud (PROMCAR 1)","authors":"Luis Rodríguez Padial,&nbsp;Andrés Íñiguez Romo,&nbsp;José Luis Bernal Sobrino,&nbsp;Ángel Cequier Fillat,&nbsp;María Teresa San Saturnino,&nbsp;Concepción Cruzado Álvarez,&nbsp;Rocío García Orta,&nbsp;Rafael Hidalgo Urbano,&nbsp;Francisco Javier Elola Somoza,&nbsp;Nicolás Rosillo Ramírez,&nbsp;Josebe Goirigolzarri Artaza,&nbsp;Ignacio Fernández Lozano,&nbsp;en representación de los comités y grupos de trabajo del proyecto PROMCAR","doi":"10.1016/j.recesp.2026.02.012","DOIUrl":"10.1016/j.recesp.2026.02.012","url":null,"abstract":"<div><div>The PROMCAR project, promoted by the Spanish Society of Cardiology and the Spanish Heart Foundation, aims to improve the health and experience of patients treated in cardiology departments within the Spanish National Health System. Its scope includes the use of patient-reported outcome measures (PROMs) and patient-reported experience measures (PREMs). The PROMCAR project was structured in 3 phases. This study addressed the first phase: the selection of questionnaires. Under the scientific direction of the steering committee, working groups were established to select a generic PROM and specific PROMs for 5 clinical conditions, as well as PREMs. Key decisions were made using an adapted consensus development conference methodology. Four previously validated questionnaires available in Spanish-language versions were unanimously selected. Recommendations were also formulated regarding the identification of target populations and the administration of the questionnaires. The selected questionnaires constitute a reference standard for implementation across cardiology departments within the Spanish National Health System, as well as for the development of a digital data analytics platform to support clinical decision-making and benchmarking to improve quality of care.</div></div>","PeriodicalId":21299,"journal":{"name":"Revista espanola de cardiologia","volume":"79 8","pages":"Pages 713-720"},"PeriodicalIF":4.2,"publicationDate":"2026-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148660489","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Gammagrafía ósea como marcador de reversibilidad en la miocardiopatía por hidroxicloroquina","authors":"Lucía Fernández Gassó,&nbsp;Elena Ruiz-Bravo,&nbsp;Luis Domínguez Gadea,&nbsp;Sara Quinones Garrido,&nbsp;Raúl Moreno,&nbsp;Gema Bonilla Hernán","doi":"10.1016/j.recesp.2025.12.014","DOIUrl":"10.1016/j.recesp.2025.12.014","url":null,"abstract":"","PeriodicalId":21299,"journal":{"name":"Revista espanola de cardiologia","volume":"79 8","pages":"Pages 729-731"},"PeriodicalIF":4.2,"publicationDate":"2026-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148660493","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Therapy (y II)","authors":"Fernando A. Navarro","doi":"10.1016/j.recesp.2026.01.003","DOIUrl":"10.1016/j.recesp.2026.01.003","url":null,"abstract":"","PeriodicalId":21299,"journal":{"name":"Revista espanola de cardiologia","volume":"79 8","pages":"Page 653"},"PeriodicalIF":4.2,"publicationDate":"2026-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148647179","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Utilidad del tiempo de obturación con difosfato de adenosina en el diagnóstico de la fuga paravalvular mitral protésica y el pronóstico tras su reparación","authors":"Yassin Belahnech,&nbsp;Gerard Martí-Aguasca,&nbsp;Bruno García del Blanco,&nbsp;Eduard Ródenas-Alesina,&nbsp;Arnau Subirà-Ingla,&nbsp;Sergio del Fresno,&nbsp;Augusto Sao-Avilés,&nbsp;Javier Solsona-Caravaca,&nbsp;Laura Galian-Gay,&nbsp;Rubén Fernández-Galera,&nbsp;Víctor González-Fernández,&nbsp;Neus Bellera-Gotarda,&nbsp;Vicenç Serra,&nbsp;Imanol Otaegui,&nbsp;Bernat Serra,&nbsp;Álvaro Calabuig,&nbsp;Toni Soriano-Colomé,&nbsp;Aitor Uribarri,&nbsp;Ignacio Ferreira-González","doi":"10.1016/j.recesp.2026.02.002","DOIUrl":"10.1016/j.recesp.2026.02.002","url":null,"abstract":"<div><h3>Introduction and objectives</h3><div>Mitral paravalvular leak (PVL) is associated with hemolysis and heart failure. It has also been linked to shear stress-induced von Willebrand factor abnormalities that prolong closure time with adenosine diphosphate (CT-ADP). The aim of this study was to assess whether CT-ADP serves as a biomarker for mitral PVL diagnosis, follow-up, and prognosis after repair.</div></div><div><h3>Methods</h3><div>In this prospective study, 89 patients (27 with moderate-to-severe mitral PVL referred for closure, group 1; 31 with prosthetic mitral valves without PVL, group 2; and 31 controls without valvular disease, group 3) underwent laboratory assessment including hemolysis markers, congestion markers, and CT-ADP. Patients with PVL underwent percutaneous or surgical repair and were followed up at 3 and 12 months. ROC analysis, linear regression, and Cox models were used to evaluate the diagnostic and prognostic value of CT-ADP.</div></div><div><h3>Results</h3><div>CT-ADP was prolonged in PVL patients (median, 214<!--> <!-->seconds) vs control groups (86 seconds in group 2 and 74<!--> <!-->seconds in group 3; <em>P</em> &lt;<!--> <!-->.001). A cutoff of<!--> <!-->&gt; 135<!--> <!-->seconds showed excellent diagnostic accuracy (AUROC, 0.96; sensitivity 89%, specificity 97%). Postprocedural CT-ADP decreased significantly after successful repair (median decrease of 79<!--> <!-->seconds) but remained unchanged in those with residual leaks. Elevated postprocedural CT-ADP (&gt;155 s) identified persistent PVL and was associated with worse 1-year outcomes (HR, 21.37; <em>P</em> <!-->=<!--> <!-->.004), including death, heart failure or hemolysis-related readmission, and reintervention.</div></div><div><h3>Conclusions</h3><div>CT-ADP appears to be a promising biomarker for diagnosing and monitoring mitral PVL. It may add value to conventional markers by reflecting shear stress-related platelet dysfunction and predicting outcomes following PVL closure.</div></div>","PeriodicalId":21299,"journal":{"name":"Revista espanola de cardiologia","volume":"79 8","pages":"Pages 691-700"},"PeriodicalIF":4.2,"publicationDate":"2026-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148660488","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}